Literature DB >> 25152934

Mapping Dynamic Changes in Ventricular Volume onto Baseline Cortical Surfaces in Normal Aging, MCI, and Alzheimer's Disease.

Sarah K Madsen, Boris A Gutman, Shantanu H Joshi, Arthur W Toga, Clifford R Jack, Michael W Weiner, Paul M Thompson.   

Abstract

Ventricular volume (VV) is a powerful global indicator of brain tissue loss on MRI in normal aging and dementia. VV is used by radiologists in clinical practice and has one of the highest obtainable effect sizes for tracking brain change in clinical trials, but it is crucial to relate VV to structural alterations underlying clinical symptoms. Here we identify patterns of thinner cortical gray matter (GM) associated with dynamic changes in lateral VV at 1-year (N=677) and 2-year (N=536) intervals, in the ADNI cohort. People with faster VV loss had thinner baseline cortical GM in temporal, inferior frontal, inferior parietal, and occipital regions (controlling for age, sex, diagnosis). These findings show the patterns of relative cortical atrophy that predict later ventricular enlargement, further validating the use of ventricular segmentations as biomarkers. We may also infer specific patterns of regional cortical degeneration (and perhaps functional changes) that relate to VV expansion.

Entities:  

Keywords:  brain imaging; imaging biomarkers*; magnetic resonance imaging; quantitative image analysis; statistical analysis; temporal/longitudinal image series analysis

Year:  2013        PMID: 25152934      PMCID: PMC4138607          DOI: 10.1007/978-3-319-02126-3_9

Source DB:  PubMed          Journal:  Multimodal Brain Image Anal (2013)


  16 in total

1.  Hippocampal atrophy and ventricular enlargement in normal aging, mild cognitive impairment (MCI), and Alzheimer Disease.

Authors:  Liana G Apostolova; Amity E Green; Sona Babakchanian; Kristy S Hwang; Yi-Yu Chou; Arthur W Toga; Paul M Thompson
Journal:  Alzheimer Dis Assoc Disord       Date:  2012 Jan-Mar       Impact factor: 2.703

2.  Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.

Authors:  Yi-Yu Chou; Natasha Leporé; Christina Avedissian; Sarah K Madsen; Neelroop Parikshak; Xue Hua; Leslie M Shaw; John Q Trojanowski; Michael W Weiner; Arthur W Toga; Paul M Thompson
Journal:  Neuroimage       Date:  2009-02-21       Impact factor: 6.556

3.  Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.

Authors:  Sean M Nestor; Raul Rupsingh; Michael Borrie; Matthew Smith; Vittorio Accomazzi; Jennie L Wells; Jennifer Fogarty; Robert Bartha
Journal:  Brain       Date:  2008-07-11       Impact factor: 13.501

4.  Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease.

Authors:  Anqi Qiu; Christine Fennema-Notestine; Anders M Dale; Michael I Miller
Journal:  Neuroimage       Date:  2009-04-15       Impact factor: 6.556

5.  Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.

Authors:  Basil H Ridha; Valerie M Anderson; Josephine Barnes; Richard G Boyes; Shona L Price; Martin N Rossor; Jennifer L Whitwell; Lisa Jenkins; Ronald S Black; Micheal Grundman; Nick C Fox
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

6.  Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects.

Authors:  Xue Hua; Suh Lee; Igor Yanovsky; Alex D Leow; Yi-Yu Chou; April J Ho; Boris Gutman; Arthur W Toga; Clifford R Jack; Matt A Bernstein; Eric M Reiman; Danielle J Harvey; John Kornak; Norbert Schuff; Gene E Alexander; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2009-07-14       Impact factor: 6.556

Review 7.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Cognitive functions and brain structures: a quantitative study of CSF volumes on Alzheimer patients and healthy control subjects.

Authors:  L O Wahlund; G Andersson-Lundman; H Basun; O Almkvist; K S Björkstén; J Sääf; L Wetterberg
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

9.  Ventricular shape biomarkers for Alzheimer's disease in clinical MR images.

Authors:  Luca Ferrarini; Walter M Palm; Hans Olofsen; Roald van der Landen; Mark A van Buchem; Johan H C Reiber; Faiza Admiraal-Behloul
Journal:  Magn Reson Med       Date:  2008-02       Impact factor: 4.668

10.  Plaque and tangle imaging and cognition in normal aging and Alzheimer's disease.

Authors:  Meredith N Braskie; Andrea D Klunder; Kiralee M Hayashi; Hillary Protas; Vladimir Kepe; Karen J Miller; S-C Huang; Jorge R Barrio; Linda M Ercoli; Prabha Siddarth; Nagichettiar Satyamurthy; Jie Liu; Arthur W Toga; Susan Y Bookheimer; Gary W Small; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2008-11-11       Impact factor: 4.673

View more
  8 in total

1.  Apolipoprotein E epsilon 4 allele is associated with ventricular expansion rate and surface morphology in dementia and normal aging.

Authors:  Florence F Roussotte; Boris A Gutman; Sarah K Madsen; John B Colby; Katherine L Narr; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2013-12-05       Impact factor: 4.673

2.  Impact of Total Knee Arthroplasty with General Anesthesia on Brain Networks: Cognitive Efficiency and Ventricular Volume Predict Functional Connectivity Decline in Older Adults.

Authors:  Haiqing Huang; Jared Tanner; Hari Parvataneni; Mark Rice; Ann Horgas; Mingzhou Ding; Catherine Price
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

3.  Folate Related Pathway Gene Analysis Reveals a Novel Metabolic Variant Associated with Alzheimer's Disease with a Change in Metabolic Profile.

Authors:  Jaleel Miyan; Charlotte Buttercase; Emma Beswick; Salma Miyan; Ghazaleh Moshkdanian; Naila Naz
Journal:  Metabolites       Date:  2022-05-24

4.  Combined effects of Alzheimer risk variants in the CLU and ApoE genes on ventricular expansion patterns in the elderly.

Authors:  Florence F Roussotte; Boris A Gutman; Sarah K Madsen; John B Colby; Paul M Thompson
Journal:  J Neurosci       Date:  2014-05-07       Impact factor: 6.167

5.  A single nucleotide polymorphism associated with reduced alcohol intake in the RASGRF2 gene predicts larger cortical volumes but faster longitudinal ventricular expansion in the elderly.

Authors:  Florence F Roussotte; Boris A Gutman; Derrek P Hibar; Neda Jahanshad; Sarah K Madsen; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Front Aging Neurosci       Date:  2013-12-19       Impact factor: 5.750

6.  Applying surface-based morphometry to study ventricular abnormalities of cognitively unimpaired subjects prior to clinically significant memory decline.

Authors:  Qunxi Dong; Wen Zhang; Cynthia M Stonnington; Jianfeng Wu; Boris A Gutman; Kewei Chen; Yi Su; Leslie C Baxter; Paul M Thompson; Eric M Reiman; Richard J Caselli; Yalin Wang
Journal:  Neuroimage Clin       Date:  2020-07-05       Impact factor: 4.881

7.  Brain structure changes over time in normal and mildly impaired aged persons.

Authors:  Charles D Smith; Linda J Van Eldik; Gregory A Jicha; Frederick A Schmitt; Peter T Nelson; Erin L Abner; Richard J Kryscio; Ronan R Murphy; Anders H Andersen
Journal:  AIMS Neurosci       Date:  2020-05-20

8.  Predicting Alzheimer's disease development: a comparison of cognitive criteria and associated neuroimaging biomarkers.

Authors:  Brandy L Callahan; Joel Ramirez; Courtney Berezuk; Simon Duchesne; Sandra E Black
Journal:  Alzheimers Res Ther       Date:  2015-11-05       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.